Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Treatment of myeloproliferative neoplasms other than chronic leukemia].

Nihon rinsho. Japanese journal of clinical medicine - 1 Oct 2009

Ohyashiki Junko H

Abstract excerpt

The discovery of JAK2 mutation has greatly facilitated the approach to diagnosis of myeloproliferative neoplasms besides chronic myeloid leukemia. Since major causes of morbidity and mortality in polycythemia vera (PV) and essential thrombocythemia (ET) are represented by thrombosis, bleeding, pr...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gene Targeting
Share to Janus Kinase 2
Share to Leukemia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Myeloproliferative Disorders

Share to Polycythemia Vera

Share to STAT Transcription Factors

Share to Thrombocythemia, Essential

Share to Thrombosis

Source

Identifiers

PMID: 19860198

Genes

JAK2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19860198-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Treatment of myeloproliferative neoplasms other than chronic leukemia].PMID 19860198Read ↗

Novel strategies for patients with chronic myeloproliferative disorders.Semantic proximity Read ↗

Myeloproliferative neoplasms.Semantic proximity Read ↗

Clinical Features of 294 Turkish Patients with Chronic Myeloproliferative Neoplasms.Semantic proximity Read ↗

Myeloproliferative neoplasms: JAK2 signaling pathway as a central target for therapy.Semantic proximity Read ↗

Chronic myeloproliferative neoplasms in the elderly.Semantic proximity Read ↗

[Recent findings and advances in treatment of myeloproliferative neoplasms].Semantic proximity Read ↗

Evidence and expertise in the management of polycythemia vera and essential thrombocythemia.Semantic proximity Read ↗

[Evidence on chronic myeloproliferative neoplasms from landmark clinical trials].Semantic proximity Read ↗

JAK2 mutation-related disease and thrombosis.Semantic proximity Read ↗

[Treatment strategies for chronic myeloid leukemia].Semantic proximity Read ↗

[Myeloproliferative neoplasms: pathophysiology and therapeutic strategy].Semantic proximity Read ↗

[Myeloproliferative diseases caused by JAK2 mutation].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.